NEOS THERAPEUTICS INC (NEOS)
Institutional ownership reported to the SEC as of Q4 2020, across 9 quarters.
36
Reporting holders
$6.7M
Reported value
1.9%
Held as options
+1
Holder change
Options share is the part of reported value carried in derivative lines rather than shares. A high figure means institutions are expressing a view on this security without owning much of it.
Holders
Quarter by quarter
Coverage begins with the quarter ending 2018-12-31. Earlier filings exist only as occasional late amendments, too sparse to describe a market, so they are not shown.
| Quarter | Holders | Value | Shares | New | Added | Trimmed | Options |
|---|---|---|---|---|---|---|---|
| Q4 2020 | 36 | $6.7M | 10,569,898 | 8 | 5 | 8 | 1.9% |
| Q3 2020 | 35 | $8.8M | 16,493,882 | 6 | 4 | 10 | 0.1% |
| Q2 2020 | 37 | $12.2M | 17,822,403 | 1 | 6 | 10 | 0.0% |
| Q1 2020 | 44 | $14.6M | 19,460,542 | 2 | 10 | 9 | 0.1% |
| Q4 2019 | 52 | $33.6M | 22,262,761 | 8 | 11 | 12 | 0.1% |
| Q3 2019 | 49 | $30.4M | 20,530,914 | 8 | 9 | 17 | 0.0% |
| Q2 2019 | 54 | $29.4M | 22,802,522 | 11 | 16 | 16 | 0.0% |
| Q1 2019 | 63 | $71.4M | 27,283,119 | 9 | 23 | 17 | 0.2% |
| Q4 2018 | 61 | $42.4M | 25,632,289 | 2 | 1 | 1 | 0.3% |